128 related articles for article (PubMed ID: 17234368)
1. Chemotherapy-related secondary leukemias: A role for DNA repair by error-prone non-homologous end joining in topoisomerase II - Induced chromosomal rearrangements.
Kantidze OL; Razin SV
Gene; 2007 Apr; 391(1-2):76-9. PubMed ID: 17234368
[TBL] [Abstract][Full Text] [Related]
2. [Illegitimate recombination as a possible mechanism of DNA-topoisomerase II induced chromosomal rearrangements].
Kantidze OL; Iarovaia OV; Klochkov DB; Razin SV
Mol Biol (Mosk); 2006; 40(5):878-85. PubMed ID: 17086989
[TBL] [Abstract][Full Text] [Related]
3. BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II.
Treszezamsky AD; Kachnic LA; Feng Z; Zhang J; Tokadjian C; Powell SN
Cancer Res; 2007 Aug; 67(15):7078-81. PubMed ID: 17671173
[TBL] [Abstract][Full Text] [Related]
4. Chromatin structural elements and chromosomal translocations in leukemia.
Zhang Y; Rowley JD
DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
[TBL] [Abstract][Full Text] [Related]
5. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells.
Frankenberg-Schwager M; Becker M; Garg I; Pralle E; Wolf H; Frankenberg D
Radiat Res; 2008 Dec; 170(6):784-93. PubMed ID: 19138034
[TBL] [Abstract][Full Text] [Related]
6. Roles of nonhomologous end-joining pathways in surviving topoisomerase II-mediated DNA damage.
Malik M; Nitiss KC; Enriquez-Rios V; Nitiss JL
Mol Cancer Ther; 2006 Jun; 5(6):1405-14. PubMed ID: 16818498
[TBL] [Abstract][Full Text] [Related]
7. Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining.
Coiteux V; Onclercq-Delic R; Fenaux P; Amor-Guéret M
Leuk Res; 2007 Mar; 31(3):353-8. PubMed ID: 16890283
[TBL] [Abstract][Full Text] [Related]
8. Type II topoisomerases--inhibitors, repair mechanisms and mutations.
Heisig P
Mutagenesis; 2009 Nov; 24(6):465-9. PubMed ID: 19762349
[TBL] [Abstract][Full Text] [Related]
9. Repositioning of ETO gene in cells treated with VP-16, an inhibitor of DNA-topoisomerase II.
Rubtsov MA; Terekhov SM; Razin SV; Iarovaia OV
J Cell Biochem; 2008 May; 104(2):692-9. PubMed ID: 18183572
[TBL] [Abstract][Full Text] [Related]
10. A molecular beacon approach to detecting RAD52 expression in response to DNA damage in human cells.
Riches LC; Lynch AM; Gooderham NJ
Toxicol In Vitro; 2010 Mar; 24(2):652-60. PubMed ID: 19799994
[TBL] [Abstract][Full Text] [Related]
11. Non-homologous end-joining for repairing I-SceI-induced DNA double strand breaks in human cells.
Honma M; Sakuraba M; Koizumi T; Takashima Y; Sakamoto H; Hayashi M
DNA Repair (Amst); 2007 Jun; 6(6):781-8. PubMed ID: 17296333
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of DNA topoisomerase II may trigger illegitimate recombination in living cells: experiments with a model system.
Umanskaya ON; Lebedeva SS; Gavrilov AA; Bystritskiy AA; Razin SV
J Cell Biochem; 2006 Oct; 99(2):598-608. PubMed ID: 16676353
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells.
Jensen LH; Dejligbjerg M; Hansen LT; Grauslund M; Jensen PB; Sehested M
BMC Pharmacol; 2004 Dec; 4():31. PubMed ID: 15575955
[TBL] [Abstract][Full Text] [Related]
14. The endless tale of non-homologous end-joining.
Weterings E; Chen DJ
Cell Res; 2008 Jan; 18(1):114-24. PubMed ID: 18166980
[TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II-mediated DNA damage.
Adachi N; Suzuki H; Iiizumi S; Koyama H
J Biol Chem; 2003 Sep; 278(38):35897-902. PubMed ID: 12842886
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a role of vertebrate Rad52 in the repair of topoisomerase II-mediated DNA damage.
Adachi N; Iiizumi S; Koyama H
DNA Cell Biol; 2005 Jun; 24(6):388-93. PubMed ID: 15941391
[TBL] [Abstract][Full Text] [Related]
17. The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1.
Smith KA; Cowell IG; Zhang Y; Sondka Z; Austin CA
Genes Chromosomes Cancer; 2014 Feb; 53(2):117-28. PubMed ID: 24327541
[TBL] [Abstract][Full Text] [Related]
18. A DNA repair player, ring finger protein 43, relieves etoposide-induced topoisomerase II poisoning.
Lerksuthirat T; Wikiniyadhanee R; Stitchantrakul W; Chitphuk S; Stansook N; Pipatpanyanugoon N; Jirawatnotai S; Dejsuphong D
Genes Cells; 2020 Nov; 25(11):718-729. PubMed ID: 32939879
[TBL] [Abstract][Full Text] [Related]
19. DNA repair and chromosomal alterations.
Natarajan AT; Palitti F
Mutat Res; 2008 Nov; 657(1):3-7. PubMed ID: 18801460
[TBL] [Abstract][Full Text] [Related]
20. Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells.
de Campos-Nebel M; Larripa I; González-Cid M
Mutat Res; 2008 Nov; 646(1-2):8-16. PubMed ID: 18812179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
